Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
about
HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.Bullous pemphigoid: end of the century overview.Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.Humanized mice as a model for rheumatoid arthritis.Immunohistological analysis of immune cells in blistering skin lesions.The role of T cells in cutaneous autoimmune disease.T cell control in autoimmune bullous skin disorders.Pemphigoid diseases: pathogenesis, diagnosis, and treatment.BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?A case report of bullous pemphigoid associated with a melanoma and review of the literature.A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid.Multiple mucosal involvement in cicatricial pemphigoid.[Bullous pemphigoid].Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.Evidence for a role of eosinophils in blister formation in bullous pemphigoid.HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 Alleles Associated to Bullous Pemphigoid in Brazilian Population.Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseasesCoagulation activation in autoimmune bullous diseases
P2860
Q33751646-95D18AE3-18C2-4512-A99C-976DD0E0D536Q33817892-01E65346-01CA-404A-9200-CC859730D271Q34157289-8077896E-0130-4C18-9B32-138FA3133A8AQ34480487-29BF5E64-F9C8-476E-B4AD-8ACDD4E9CA32Q34583089-12D0705C-226A-4F6E-A2C6-A9BDF31279F7Q34731162-9883B74D-8C6F-4089-86E5-E8C760B29E3BQ35770601-EB905D1C-012A-42AF-BA64-3B11381F10E1Q36277428-98AB7BF5-A9DF-4FEC-AA35-775151033B25Q36467108-0A4D9BDA-815F-40B1-A185-C5E99A8977C2Q37933427-86832B69-D3F1-468D-9457-4142C646DCC9Q38193888-66076DC5-7F04-4D69-9D53-C54ACA8EDDE1Q38985282-45C49A87-6C2C-4226-8B47-AF49B7736719Q39094653-6A9C066F-14BF-4A0A-94A0-79D6B284F745Q39096598-21656A92-4FB5-4972-BE1F-C93D2985606EQ39333039-63F3FDBC-A0B0-4B5C-AF54-6241E89763B1Q40954723-DBA8B883-5084-45D0-A708-DF2AE30CA6BDQ42486946-7C204575-9A84-492F-95E1-6491CF2D3C67Q42923527-281899ED-BE95-447C-BAAE-4ABD0EA72BF7Q44346755-2E3D31A7-9703-43AF-A477-8D910BA55AE6Q46244822-5CDB3984-B1AD-4F84-8FDB-BA6D7F89632DQ46425853-7B781796-FEDB-4DDB-8191-6DD99842508BQ48508517-CE6E8EE8-6A7F-42F2-BA0C-C552237F5765Q52870496-B24A9809-B8BB-414C-8938-72858DB6250AQ52996461-4370D9AE-763F-4897-BE2F-D8E60343475DQ53669315-15C913E3-B104-48AE-9F63-4B7922ED3F15Q55104920-5594F5A6-09A0-4017-8479-8AB31B952B38Q58418431-4F0E47A9-1EEE-4395-B4AE-0A66DF3078ABQ58418493-E0740FCC-56B6-454B-851E-C1AEEFBABFB1
P2860
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification and characteriz ...... patients and healthy controls.
@en
Identification and characteriz ...... patients and healthy controls.
@nl
type
label
Identification and characteriz ...... patients and healthy controls.
@en
Identification and characteriz ...... patients and healthy controls.
@nl
prefLabel
Identification and characteriz ...... patients and healthy controls.
@en
Identification and characteriz ...... patients and healthy controls.
@nl
P2093
P2860
P356
P1476
Identification and characteriz ...... patients and healthy controls.
@en
P2093
H Grosse-Wilde
L Borradori
L Büdinger
S Ferencik
P2860
P304
P356
10.1172/JCI3335
P407
P577
1998-12-01T00:00:00Z